CVS Health Corporation (CVS) with a market cap of $105.4 billion provides health insurance, pharmacy benefit management, and retail pharmacy services. CVS stock has surged 53.8% in the past year, outperforming the S&P 500 Index and the State Street Health Care Select Sector ETF. However, shares fell nearly 2% after reporting a Q3 2025 loss of $3.13 per share due to a goodwill impairment charge. Analysts expect adjusted EPS to grow 22.7% year-over-year. The consensus rating is a “Strong Buy” with a mean price target of $94.74. Bernstein raised CVS Health’s price target to $91.

Read more at Barchart: Are Wall Street Analysts Predicting CVS Health Stock Will Climb or Sink?